See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Social Media
Tariffs
Natural Disasters
Donald Trump
Soccer
Real Madrid
South America
Golf
Tennis
Facebook
Trade
Published • loading... • Updated

2024's blockbusters: Top 25 drugs by sales

Summary by Drug Discovery and Development
In 2024, Merck’s Keytruda continued to dominate with $29.5 billion in sales, growing 18% over 2023’s $25 billion in sales. Yet the GLP-1 class is nipping at Keytruda’s heels and a patent expiry threatens the oncology stalwart’s reign. Novo Nordisk’s Ozempic surged 38% to $17.5 billion while Eli Lilly’s Mounjaro exploded with 969% growth to… The post 2024’s blockbusters: Top 25 drugs by sales appeared first on Drug Discovery and Development.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Drug Discovery and DevelopmentDrug Discovery and Development

2024's blockbusters: Top 25 drugs by sales

In 2024, Merck’s Keytruda continued to dominate with $29.5 billion in sales, growing 18% over 2023’s $25 billion in sales. Yet the GLP-1 class is nipping at Keytruda’s heels and a patent expiry threatens the oncology stalwart’s reign. Novo Nordisk’s Ozempic surged 38% to $17.5 billion while Eli Lilly’s Mounjaro exploded with 969% growth to… The post 2024’s blockbusters: Top 25 drugs by sales appeared first on Drug Discovery and Development.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Discovery and Development broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Merck

Merck

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal